| 000 | 01780 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512032801.0 | ||
| 264 | 0 | _c19881201 | |
| 008 | 198812s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19881115)62:10<2263::aid-cncr2820621032>3.0.co;2-t _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aParikh, P M | |
| 245 | 0 | 0 |
_aA prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatin. _h[electronic resource] |
| 260 |
_bCancer _cNov 1988 |
||
| 300 |
_a2263-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDexamethasone _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetoclopramide _xtherapeutic use |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aCharak, B S | |
| 700 | 1 | _aBanavali, S D | |
| 700 | 1 | _aKoppikar, S B | |
| 700 | 1 | _aGiri, N | |
| 700 | 1 | _aNadkarni, P | |
| 700 | 1 | _aSaikia, T K | |
| 700 | 1 | _aGopal, R | |
| 700 | 1 | _aAdvani, S H | |
| 773 | 0 |
_tCancer _gvol. 62 _gno. 10 _gp. 2263-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19881115)62:10<2263::aid-cncr2820621032>3.0.co;2-t _zAvailable from publisher's website |
| 999 |
_c3058597 _d3058597 |
||